Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Conditions

Hypertrophic Cardiomyopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California - San Francisco, San Francisco, California, United States
Contact: Study coordinator (Cynthia Partida-Higuera, CCRP) · Cynthia.Partida-Higuera@ucsf.edu · 415-514-1125
Contact: Principal Investigator (Theodore P Abraham, M.D)

Study leads

Theodore P Abraham, M.D
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pediatric Cardiomyopathy Mutation Analysis

Cardiomyopathies · Dilated Cardiomyopathy · Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Indianapolis, United States

A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Beijing, China · Beijing, China

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Anchorage, United States · Tucson, United States

LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.

Hypertrophic Cardiomyopathy (HCM)

Abroad (travel likely)RecruitingPHASE3

Angers, France · Bordeaux, France